Your session is about to expire
← Back to Search
Behavioural Intervention
Cognitive Fitness for Depression
N/A
Waitlist Available
Led By Kevin Manning, Ph.D.
Research Sponsored by UConn Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Current major or mild depression despite ongoing treatment
current major or mild depression despite ongoing treatment
Must not have
Neurological disorders (e.g., stroke, epilepsy, brain injury with loss of consciousness > 30 minutes, brain tumors, demyelinating diseases)
Clinical diagnosis of dementia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-treatment and six weeks later when treatment has ended
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing if computerized activities can improve thinking and depression in older adults with antidepressants, and if there are changes to brain activity.
Who is the study for?
This trial is for older adults who are experiencing depression and cognitive issues despite being treated with antidepressants. Participants must be able to read and write in English, have been on antidepressants for at least 8 weeks, and be under a doctor's care. People with psychosis, other major psychiatric disorders besides personality or generalized anxiety disorders, recent substance use disorders, dementia, significant neurological conditions or severe vision problems cannot join.
What is being tested?
The study is testing whether computerized cognitive exercises can improve thinking abilities and reduce symptoms of depression in older adults already taking antidepressants. It also aims to see if these activities change brain activity as seen on MRI scans.
What are the potential side effects?
Since the intervention involves non-invasive computer activities designed to enhance cognitive function, there are no direct physical side effects expected from the treatment itself. However, participants may experience fatigue or frustration.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am currently experiencing depression despite treatment.
Select...
I am currently experiencing depression despite treatment.
Select...
I have been taking an antidepressant for at least 8 weeks.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a neurological disorder like stroke, epilepsy, or brain injury.
Select...
I have been diagnosed with dementia.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre-treatment and six weeks later when treatment has ended
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-treatment and six weeks later when treatment has ended
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in attention / cognitive flexibility as measured by the Trail Making Part B test
Change in depression symptom severity as measured with the Montgomery Asberg Depression Rating Scale (MADRS)
Secondary study objectives
Change in attention processing speed as measured with the Flanker Test of Response Inhibition from the NIH Cognitive Toolbox
Change in problem solving/speed/spatial memory as measured with the NIH Toolbox fluid composite scales
Change in self-reported depressive symptoms measured with the Carroll Depression Rating Scale
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Computerized Cognitive Remediation of Executive Functioning (CCR-EF)Experimental Treatment1 Intervention
Initially 10 hours of processing speed exercises from "Brain HQ", (the 3 exercises are auditory tone sweep, visual processing \[Double Decision\], visual sweep).
Following the 8-10 hours of Brain HQ, participants complete 8-10 hours of "Ultimate Word Master" before completing 16-20 hours of "Neurogrow" (formerly called "Catch the Ball").
Participants are asked to complete approximately 28-42 hours of computerized brain training over 4-6 weeks.
Group II: Active ControlActive Control1 Intervention
Patients in the active control arm will complete three activities according to a standard protocol: 1) play a visuospatially oriented computer game (Myst), 2) watch computer-based educational programs on art, history, literature, and 3) play computer games online through the Brain HQ platform; games include crossword puzzles, soduko, paddleboard, and word search. Participants will complete a total of 32-42 hours of training over 4-6 weeks. Time spent on each task will be evenly divided (15 minutes of each task everday).
Find a Location
Who is running the clinical trial?
UConn HealthLead Sponsor
215 Previous Clinical Trials
60,583 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,931 Previous Clinical Trials
2,744,904 Total Patients Enrolled
Kevin Manning, Ph.D.Principal Investigator - UConn Health
UConn Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been taking an antidepressant for at least 8 weeks.I am currently experiencing depression despite treatment.I am being treated for depression by a doctor.I have a neurological disorder like stroke, epilepsy, or brain injury.I have been diagnosed with dementia.I am currently experiencing depression despite treatment.I am being treated for depression by a doctor.I have been taking an antidepressant for at least 8 weeks.
Research Study Groups:
This trial has the following groups:- Group 1: Active Control
- Group 2: Computerized Cognitive Remediation of Executive Functioning (CCR-EF)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Mild Cognitive Impairment Patient Testimony for trial: Trial Name: NCT04790630 — N/A